Sunday, October 15, 2023

Week in Review 41/23


Welcome and thanks for reading!

In this review, I will make a summary of important and interesting news and events over the last week related to my portfolio holdings. Also, I will put together some interesting articles from other websites that caught my attention during the past week.

Received Dividends:

October 10, 2023

  • €121.02– Altria Group, Inc. (MO)
  • €25.97– Best Buy Co., Inc. (BBY)

October 12, 2023

  • €26.36– Medical Properties Trust, Inc. (MPW)

October 13, 2023

  • €49.21– Tele2 AB (TEL2)
  • €78.30– Philip Morris International Inc. (PM)
  • €19.84– Illinois Tool Works Inc. (ITW)
  • €27.64– Global X SuperDividend™ ETF (SDIV)

Week 41: Total net dividends €348.34

Dividend income is reported after the deduction of taxes. Check more at my Monthly Dividend sheet.

Portfolio Holdings News:

October 9, 2023

  • Bristol-Myers Squibb Company (BMY) Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics; BMY and Mirati Therapeutics, Inc. (MRTX) today announced that they have entered into a definitive merger agreement under which Bristol Myers Squibb has agreed to acquire Mirati for $58.00 per share in cash, for a total equity value of $4.8 billion. Mirati stockholders will also receive one non-tradeable Contingent Value Right (CVR) for each Mirati share held, potentially worth $12.00 per share in cash, representing an additional $1.0 billion of value opportunity. The transaction was unanimously approved by both the Bristol Myers Squibb and the Mirati Boards of Directors.

October 10, 2023

  • PepsiCo, Inc. (PEP) Reports Third-Quarter 2023 Results; PEP reports Non-GAAP EPS of $2.25, beating analyst estimates by $0.10 and increased 16% year-over-year. Revenue of $23.45 billion was in line with analysts' expectations, and increased by 6.7% compared to the same quarter last year. For fiscal year 2023, PEP now expects to deliver 13 percent core constant currency EPS growth (previously 12 percent). For fiscal year 2024, PEP expects to deliver results towards the upper end of long-term target ranges for both organic revenue and core constant currency EPS growth.

October 11, 2023

October 12, 2023

  • Walgreens Boots Alliance, Inc. (WBA) Reports Fiscal Year 2023 Earnings; WBA reports fourth quarter Non-GAAP EPS of $0.67, missing analyst estimates by $0.02 and decreasing 37% year-over-year. Revenue of $35.42 billion beats analyst estimates by $580 million and increased 9.2% versus the same quarter last year. For FY2024 Management guides Adjusted EPS of $3.20 to $3.50.

  • Lockheed Martin Corporation (LMT) has secured a $379.58 million firm-fixed-price order against a previously issued basic ordering pact.

October 13, 2023

Articles that caught my attention:

Thanks for stopping by, have a nice next week!

No comments:

Post a Comment